GUJTHEM430.00

Gujarat Themis Biosyn Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersRPGLIFEGUFICBIOORCHPHARMAUNICHEMLABFDCIOLCPMOREPENLABINNOVACAPMcap ₹4,685 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q1 FY27
30/06/2026
Revenue from Operations43.8
Other Income0.1
Total Income43.9
Expenses
+ Cost of Materials Consumed7.7
+ Changes in Inventories-3.9
+ Employee Benefit Expense4.7
+ Finance Costs1.8
+ Depreciation & Amortisation4.0
+ Other Expenses14.5
Total Expenses28.8
EBITDA20.8
EBIT16.8
Profit
PBT before Exceptional Items15.2
Pretax Income15.2
+ Current Tax2.7
+ Deferred Tax1.4
Tax Expense4.1
Net Income11.1
+ Net Income — Continuing Ops11.1
+ Other Comprehensive Income0.0
Total Comprehensive Income11.1
Net Income to Common11.1
Per Share
Basic EPS1.02
Diluted EPS1.02
Other Comprehensive Income — detail
+ Other Comprehensive Income0.0
+ Tax on Items NOT to be Reclassified-0.0
Comprehensive Income — Owners of Parent11.1
Per Share — as-filed variants
Basic EPS — Continuing Operations1.02
Diluted EPS — Continuing Operations1.02
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit40.0
Gross Margin %91.28
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)15.2
Net Income Adj (tax-effected)11.1
EPS Adj1.02
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.00
Paid Up Equity Capital10.9
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.